Infinity Pharmaceuticals

Infinity Pharmaceuticals Retained Earnings

The Retained Earnings of Infinity Pharmaceuticals (INFIQ) as of Nov 20, 2026 is -855.95 M USD. In the previous year, Retained Earnings was -811.58 M USD — a change of 5.47% (lower).

Retained Earnings

-855.95 MUSD

YoY

5.47%

Last updated:

Retained Earnings of Infinity Pharmaceuticals is 2022 -855.95 M USD. Retained Earnings of Infinity Pharmaceuticals was 2021 -811.58 M USD. It decreases by 5.47% lower compared to the previous year.

The Infinity Pharmaceuticals Retained Earnings history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Retained Earnings
Date
Retained Earnings
Jan 1, 2015
-595.60 M USD
Jan 1, 2016
-625.70 M USD
Jan 1, 2017
-667.50 M USD
Jan 1, 2018
-678.80 M USD
Jan 1, 2019
-725.83 M USD
Jan 1, 2020
-766.32 M USD
Jan 1, 2021
-811.58 M USD
Jan 1, 2022
-855.95 M USD
The Infinity Pharmaceuticals Retained Earnings history
YEARRetained EarningsYoY
-855.95 MUSD+5.47%
-811.58 MUSD+5.91%
-766.32 MUSD+5.58%
-725.83 MUSD+6.93%
-678.80 MUSD+1.69%
-667.50 MUSD+6.68%
-625.70 MUSD+5.05%
-595.60 MUSD+27.48%
-467.20 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Infinity Pharmaceuticals Stock analysis

What does Infinity Pharmaceuticals do? Infinity Pharmaceuticals Inc. is a biopharmaceutical company based in Cambridge, Massachusetts. It was founded in 2001 and focuses on the discovery and development of novel therapies for cancer and other serious diseases. Infinity Pharmaceuticals is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Infinity Pharmaceuticals stock

Retained Earnings of Infinity Pharmaceuticals is -855.95 M USD in 2022.

Retained Earnings of Infinity Pharmaceuticals changed from -811.58 M USD to -855.95 M USD, representing a 5.47% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Retained Earnings Infinity Pharmaceuticals since 2006 – with annual values, charts, and detailed analysis.

Retained earnings are the cumulative net income kept in the business rather than paid out as dividends. They fund future growth and operations.

Retained Earnings's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Retained Earnings's Infinity Pharmaceuticals historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Infinity Pharmaceuticals

All Key Metrics — Infinity Pharmaceuticals